Antimicrobial prescribing: cefiderocol [ES31], NICE (published 3rd December 2020)

This evidence review covers the safety and efficacy data for this intravenous siderophore cephalosporin antibiotic. Three RCTs are reviewed, one of which was for use in carbapenem-resistant gram-negative organisms. Evidence limitations and potential place in therapy are covered
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news